» Articles » PMID: 26733722

Mechanism of Vascular Dysfunction Due to Circulating Factors in Women with Pre-eclampsia

Overview
Journal Clin Sci (Lond)
Date 2016 Jan 7
PMID 26733722
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating factors have been proposed to play a major role in the pathophysiology of endothelial dysfunction in pre-eclampsia (PE), which is defined as new-onset hypertension with proteinuria after 20 weeks of gestation. However, the mechanisms leading to altered vascular reactivity remain unclear. We hypothesized that circulating factors lead to endothelial dysfunction by increasing oxidative stress and reducing nitric oxide (NO) and prostaglandin (PG) bioavailability. Pregnant rat uterine and mesenteric arteries were incubated overnight with 3% normotensive (NP) or PE plasma collected from women upon admission to hospital. Responses to methacholine (MCh) were obtained using wire myography to assess endothelial function pathways. Vascular superoxide level was measured via dihydroethidium staining and nitric oxide synthase (NOS) expression via Western blots. PE plasma significantly increased superoxide levels and impaired endothelial dysfunction in uterine arteries (Emax 79.9±5.6% compared with 44.9±6.3%, P=0.0004), which was restored in the presence of oxidant scavengers or PG synthesis inhibition. Uterine artery vasodilation was abolished in the presence of pan-NOS inhibitor (P<0.0001) in both NP- and PE-treated vessels, but inducible nitric oxide synthase (iNOS)-dependent vasodilation was present only in NP-treated arteries. Uterine arteries exposed to PE plasma exhibit an increased endothelial NOS expression and a decreased iNOS expression. PE plasma did not alter endothelial function in mesenteric arteries, suggesting that the effect of circulating factors was vascular-bed-specific. We have shown that circulating factors lead to endothelial dysfunction via altered oxidative stress and vasodilator pathways. The present study contributes to our understanding of the pathophysiology and finding a potential target for intervention in PE.

Citing Articles

Clinical Analysis of Postpartum Preeclampsia After an Uncomplicated Pregnancy.

Fehr S, Frelier S Cureus. 2024; 16(4):e57834.

PMID: 38721196 PMC: 11077498. DOI: 10.7759/cureus.57834.


Oxidative Regulation of Vascular Ca1.2 Channels Triggers Vascular Dysfunction in Hypertension-Related Disorders.

Hu X, Zhang L Antioxidants (Basel). 2022; 11(12).

PMID: 36552639 PMC: 9774363. DOI: 10.3390/antiox11122432.


Uteroplacental Circulation in Normal Pregnancy and Preeclampsia: Functional Adaptation and Maladaptation.

Hu X, Zhang L Int J Mol Sci. 2021; 22(16).

PMID: 34445328 PMC: 8395300. DOI: 10.3390/ijms22168622.


Preeclampsia and Cardiovascular Risk for Offspring.

Wojczakowski W, Kimber-Trojnar Z, Dziwisz F, Slodzinska M, Slodzinski H, Leszczynska-Gorzelak B J Clin Med. 2021; 10(14).

PMID: 34300320 PMC: 8306208. DOI: 10.3390/jcm10143154.


single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia.

Pereira D, Sandrim V, Palei A, Amaral L, Belo V, Lacchini R Pharmacogenomics. 2021; 22(8):451-464.

PMID: 33944612 PMC: 9552901. DOI: 10.2217/pgs-2021-0006.